Status:
RECRUITING
SENOVIE France - Therapeutic Mobility and Breast Cancer
Lead Sponsor:
Institut de Recherche pour le Developpement
Collaborating Sponsors:
The French Institute for Demographic Studies (INED)
Saint-Louis Hospital, Paris, France
Conditions:
Breast Cancer Female
Eligibility:
FEMALE
18+ years
Brief Summary
Background In France, there were 61,214 new cases of breast cancer in France in 2023 with an estimated prevalence in 2017 of 913,089 people. It is thus the most common cancer in women, with an incide...
Detailed Description
Background In 2023, with 61,214 new cases diagnosed in France, breast cancer accounts for 33% of women's cancers and is the most common cancer in women. With an estimated prevalence in 2017 of 913089...
Eligibility Criteria
Inclusion
- Women aged 18 or more
- Women who consult in one of the partner hospitals of the study
- For groups 1: women born in a country of sub-Saharan Africa
- For group 2: women born in France
- Have been diagnosed with breast cancer between the 1st of January 2014 and the 31st of December 2020. As data collection will start in 2024, this is to be able to examine women's life trajectories at least 4 years after cancer diagnosis, and maximum 10 years after their diagnosis, which is the length of the follow-up in hospital services where recruitment will take place.
Exclusion
- Does not speak French
- Under 18 years old
- Have been diagnosed with breast cancer before 2014 and after 2020
Key Trial Info
Start Date :
March 25 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 31 2025
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT06503393
Start Date
March 25 2024
End Date
March 31 2025
Last Update
July 16 2024
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Robert Ballanger Hospital Aulnay-Sous-Bois
Aulnay-sous-Bois, France
2
Saint-Louis University Hospital AP-HP
Paris, France
3
Delafontaine Hospital Saint-Denis
Saint-Denis, France